secwatch.observer — SEC 8-K summary
======================================

Issuer:     CervoMed Inc. (CRVO)
CIK:        0001053691
Form:       8-K
Filed at:   2026-06-09T10:02:03+00:00
Accession:  0001437749-26-019909
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CervoMed stockholders approve all four proposals at 2026 annual meeting
-----------------------------------------------------------------------

- Elected eight directors with 3.1M+ votes for each; broker non-votes of ~3.0M on each.
- Ratified RSM US LLP as auditor for FY 2026: 6,092,751 for, 21,433 against.
- Approved advisory say-on-pay for named executive officers: 3,073,013 for, 104,221 against.
- Approved Amendment No. 1 to 2025 Equity Incentive Plan: 3,044,744 for, 132,860 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926019909/0001437749-26-019909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1053691/000143774926019909/crvo20260609_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-019909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer